Zobrazeno 1 - 10
of 427
pro vyhledávání: '"Rogerio A Lobo"'
Autor:
Carey E Gleason, N Maritza Dowling, Firat Kara, Taryn T James, Hector Salazar, Carola A Ferrer Simo, Sherman M Harman, JoAnn E Manson, Dustin B Hammers, Frederick N Naftolin, Lubna Pal, Virginia M Miller, Marcelle I Cedars, Rogerio A Lobo, Michael Malek-Ahmadi, Kejal Kantarci
Publikováno v:
PLoS Medicine, Vol 21, Iss 11, p e1004435 (2024)
BackgroundFindings from Kronos Early Estrogen Prevention Study (KEEPS)-Cog trial suggested no cognitive benefit or harm after 48 months of menopausal hormone therapy (mHT) initiated within 3 years of final menstrual period. To clarify the long-term e
Externí odkaz:
https://doaj.org/article/02cef135864546c9886d87328456d7cf
Autor:
Carey E Gleason, N Maritza Dowling, Whitney Wharton, JoAnn E Manson, Virginia M Miller, Craig S Atwood, Eliot A Brinton, Marcelle I Cedars, Rogerio A Lobo, George R Merriam, Genevieve Neal-Perry, Nanette F Santoro, Hugh S Taylor, Dennis M Black, Matthew J Budoff, Howard N Hodis, Frederick Naftolin, S Mitchell Harman, Sanjay Asthana
Publikováno v:
PLoS Medicine, Vol 12, Iss 6, p e1001833; discussion e1001833 (2015)
BACKGROUND:Menopausal hormone therapy (MHT) reportedly increases the risk of cognitive decline in women over age 65 y. It is unknown whether similar risks exist for recently postmenopausal women, and whether MHT affects mood in younger women. The anc
Externí odkaz:
https://doaj.org/article/f30698146e4d4347887f08704e21489d
Autor:
Enrico Carmina, Rogerio A. Lobo
Publikováno v:
Diagnostics, Vol 12, Iss 10, p 2313 (2022)
Polycystic Ovary Syndrome (PCOS) represents a heterogeneous disorder and, using Rotterdam diagnostic criteria, four main phenotypes (A, B, C, and D) have been distinguished. However, it remains unclear whether lean versus obesity status influences fi
Externí odkaz:
https://doaj.org/article/879f27c81f0b4b11bf152fdd115e0752
Publikováno v:
F&S Reports. 3:3-7
The availability of direct-to-consumer (DTC) testing has dramatically increased over the past 2 decades, particularly those targeted at reproduction and fertility. Several ethical concerns exist with regard to DTC tests, including the lack of governm
Autor:
Céline Gérard, Jean-François Arnal, Maud Jost, Jonathan Douxfils, Françoise Lenfant, Coralie Fontaine, René Houtman, David F. Archer, Robert L. Reid, Rogerio A. Lobo, Ulysse Gaspard, Herjan J.T. Coelingh Bennink, Mitchell D. Creinin, Jean-Michel Foidart
Publikováno v:
Expert review of clinical pharmacology, vol 15, iss 2
Gerard, C, Arnal, J-F, Jost, M, Douxfils, J, Lenfant, F, Fontaine, C, Houtman, R, Archer, D F, Reid, R L, Lobo, R A, Gaspard, U, Coelingh Bennink, H J T, Creinin, M D & Foidart, J-M 2022, ' Profile of estetrol, a promising native estrogen for oral contraception and the relief of climacteric symptoms of menopause ', Expert review of clinical pharmacology, vol. 15, no. 2, pp. 121-137 . https://doi.org/10.1080/17512433.2022.2054413
Gerard, C, Arnal, J-F, Jost, M, Douxfils, J, Lenfant, F, Fontaine, C, Houtman, R, Archer, D F, Reid, R L, Lobo, R A, Gaspard, U, Coelingh Bennink, H J T, Creinin, M D & Foidart, J-M 2022, ' Profile of estetrol, a promising native estrogen for oral contraception and the relief of climacteric symptoms of menopause ', Expert review of clinical pharmacology, vol. 15, no. 2, pp. 121-137 . https://doi.org/10.1080/17512433.2022.2054413
Introduction: Estrogens used in women’s healthcare have been associated with increased risks of venous thromboembolism (VTE) and breast cancer. Estetrol (E4), an estrogen produced by the human fetal liver, has recently been approved for the first t
Autor:
Bruna Silva Araújo, Camila de Oliveira Nuñes, José Maria Soares-Jr, Gustavo Arantes Rosa Maciel, Ricardo Simoes, Maria Cândida Pinheiro Baracat, Rogerio A. Lobo, Edmund Chada Baracat
Publikováno v:
Reproductive Sciences. 27:455-460
Polycystic ovary syndrome (PCOS) affects 6% to 20% of reproductive age women and is the most frequent cause of anovulatory infertility. Its physiopathology may result in part from hypothalamic alterations in the pulsatile secretion of gonadotropin-re
Autor:
Taryn T. James, N. Maritza Dowling, Carola A. Ferrer Simó, Megan Zuelsdorff, Shenikqua Bouges, Nickolas H. Lambrou, Carol A Van Hulle, Adrienne L. Johnson, Mary F. Wyman, Hector Salazar, Emre Umucu, Firat Kara, JoAnn E. Manson, Eliot A Brinton, Marcelle I. Cedars, Rogerio A. Lobo, Genevieve Neal‐Perry, Nanette F Santoro, Frederick Naftolin, Sherman M. Harman, Lubna Pal, Virginia M. Miller, Kejal Kantarci, Carey E. Gleason
Publikováno v:
Alzheimer's & Dementia. 17
Autor:
Firat Kara, Robert I. Reid, Christopher G. Schwarz, Nirubol Tosakulwong, Timothy G. Lesnick, Samantha M. Zuk, June Kendall‐Thomas, Kaely Thostenson, Denise A. Reyes, Julie A. Fields, Matthew L. Senjem, Hoon‐Ki Min, Val J. Lowe, Clifford R. Jack, Kent R. Bailey, Taryn T. James, Rogerio A. Lobo, JoAnn E. Manson, Lubna Pal, Dustin B. Hammers, Michael H. Malek‐Ahmadi, Marcelle I. Cedars, Frederick Naftolin, Virginia M. Miller, Sherman M. Harman, N. Maritza Dowling, Carey E. Gleason, Kejal Kantarci
Publikováno v:
Alzheimer's & Dementia. 17
Autor:
Howard N. Hodis, Eliot A. Brinton, Rogerio A. Lobo, Carey E. Gleason, Hugh S. Taylor, Matthew J. Budoff, S. Mitchell Harman, Nanette Santoro, N. Maritza Dowling, Virginia M. Miller, Dennis M. Black, Kejal Kantarci, Lubna Pal, JoAnn E. Manson, Fredrick Naftolin, Muthuvel Jayachandran, Marcelle I. Cedars, Sanjay Asthana
Publikováno v:
Menopause (New York, N.Y.), vol 26, iss 9
Miller, Virginia M; Naftolin, Fredrick; Asthana, Sanjay; Black, Dennis M; Brinton, Eliot A; Budoff, Matthew J; et al.(2019). The Kronos Early Estrogen Prevention Study (KEEPS): what have we learned?. Menopause (New York, N.Y.), 1-1. doi: 10.1097/gme.0000000000001326. UCLA: Retrieved from: http://www.escholarship.org/uc/item/1zc1b54k
Menopause (New York, N.y.)
Miller, Virginia M; Naftolin, Fredrick; Asthana, Sanjay; Black, Dennis M; Brinton, Eliot A; Budoff, Matthew J; et al.(2019). The Kronos Early Estrogen Prevention Study (KEEPS): what have we learned?. Menopause (New York, N.Y.), 1-1. doi: 10.1097/gme.0000000000001326. UCLA: Retrieved from: http://www.escholarship.org/uc/item/1zc1b54k
Menopause (New York, N.y.)
OBJECTIVE:The Kronos Early Estrogen Prevention Study (KEEPS) was designed to address gaps in understanding the effects of timely menopausal hormone treatments (HT) on cardiovascular health and other effects of menopause after the premature terminatio
Autor:
James H. Liu, Ginger D. Constantine, Rogerio A. Lobo, Brian Bernick, Sebastian Mirkin, James H. Pickar, Annette M. Shadiack, Frank Z. Stanczyk
Publikováno v:
Menopause (New York, N.y.)
Objective: In the REPLENISH trial, women receiving TX-001HR—an oral, softgel capsule, combining 17β-estradiol (E2) and progesterone (E2 mg/P4 mg 1/100, 0.5/100), had significantly improved vasomotor symptoms, while having their endometrium protect